HistoRx

Fluidigm of South San Francisco, Calif., has received US Patent No.

University College Dublin of Dublin, Ireland, has received US Patent No. 8,116,551, "Method and system for image analysis." A method for determining the level of expression of objects of interest using an automated image analysis system is claimed.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – HistoRx today said that it has licensed from Yale University a new melanoma assay based on the Aqua technology invented at Yale.

IP Roundup

Premium

Life Technologies, Agilent Technologies, Illumina, HistoRx, the United States of America

New Product Watch

Premium

Fluidigm's DeltaGene Assays, SNPtype Assays, and Access Array Target-specific Primers; HistoRx's Access Aqua and Aqua Prep Services

The firms will co-develop a new tissue-based imaging and analysis solutions for protein biomarkers.

Pairings

Premium

Daniel Forche, Heiner Dreismann

People in the News

Premium

HistoRx adds former Roche CEO Heiner Dreismann to board; Thermo Fisher forms SAB; Sage Science names Paul Ventura as director of sales.

Pages

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.